porphyria cutanea tarda

Porphyria cutanea tarda is a rare, acquired or genetic disorder characterized by a deficiency of the uroporphyrinogen III decarboxylase (UROD) enzyme. This condition leads to an accumulation of porphyrins in the skin, causing blistering and scarring. Porphyria cutanea tarda is often associated with hepatocellular carcinoma, iron overload, and hemochromatosis. The disorder can be managed with treatment, but early diagnosis is crucial to prevent long-term complications.

Signs and symptoms

The primary symptoms of porphyria cutanea tarda include blistering and scarring of the skin, particularly in areas exposed to the sun. Patients may also experience hyperpigmentation, hypertrichosis, and scarring alopecia. In severe cases, porphyria cutanea tarda can lead to disfigurement and mobility issues. Some individuals may also experience neurological symptoms, such as peripheral neuropathy.

Causes and pathophysiology

Porphyria cutanea tarda is caused by a deficiency of the uroporphyrinogen III decarboxylase (UROD) enzyme, which is involved in the heme biosynthesis pathway. This deficiency leads to an accumulation of porphyrins in the skin, causing photosensitivity and oxidative stress. The condition can be acquired or genetic, with genetic cases often associated with mutations in the UROD gene. Iron overload and hemochromatosis are also common causes of porphyria cutanea tarda.

Diagnosis

The diagnosis of porphyria cutanea tarda is based on a combination of clinical evaluation, laboratory tests, and genetic analysis. Blood tests can detect elevated levels of porphyrins in the blood, while urine tests can detect porphyrinuria. Skin biopsy may also be performed to confirm the diagnosis. Genetic testing can identify mutations in the UROD gene.

Treatment

Treatment for porphyria cutanea tarda typically involves phlebotomy to reduce iron overload and porphyrin levels. Medications, such as hydroxychloroquine and corticosteroids, may also be used to manage symptoms. Sun protection measures, such as sunscreen and protective clothing, are also essential to prevent photosensitivity. In severe cases, liver transplantation may be necessary.

Epidemiology

Porphyria cutanea tarda is a rare disorder, with an estimated prevalence of 1 in 20,000 to 1 in 50,000 people. The condition can affect individuals of all ages and ethnicities, although it is more common in European populations. Familial cases are often associated with autosomal dominant inheritance patterns. Environmental factors, such as excessive sun exposure and chemical exposure, can also contribute to the development of porphyria cutanea tarda.

Category:Genetic disorders Category:Rare diseases Category:Dermatological conditions